Multi-drug-resistant tuberculosis cost-effectiveness of therapy: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Multi-drug-resistant tuberculosis}} | {{Multi-drug-resistant tuberculosis}} | ||
{{CMG}}; {{AE}} {{AL}} | |||
==Overview== | ==Overview== | ||
| Line 9: | Line 10: | ||
*When including productivity losses (e.g., lost income) experienced by patients while undergoing treatment, costs are even higher.<ref name="CDC"> {{cite web| url=http://www.cdc.gov/tb/topic/drtb/default.htm| title= CDC Drug-Resistant TB}}</ref> | *When including productivity losses (e.g., lost income) experienced by patients while undergoing treatment, costs are even higher.<ref name="CDC"> {{cite web| url=http://www.cdc.gov/tb/topic/drtb/default.htm| title= CDC Drug-Resistant TB}}</ref> | ||
{| | {| | ||
|[[File:The Costly Burden of MDR-TB.jpg|thumb|550px|left|Image obtained from CDC | |[[File:The Costly Burden of MDR-TB.jpg|thumb|550px|left|Image obtained from CDC<ref name="CDC"> {{cite web| url=http://www.cdc.gov/tb/topic/drtb/default.htm| title= CDC Drug-Resistant TB}}</ref>]] | ||
|} | |} | ||
Revision as of 20:25, 26 September 2014
|
Multi-drug-resistant tuberculosis Microchapters |
|
Differentiating Multi-drug-resistant tuberculosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Multi-drug-resistant tuberculosis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis cost-effectiveness of therapy |
|
FDA on Multi-drug-resistant tuberculosis cost-effectiveness of therapy |
|
CDC on Multi-drug-resistant tuberculosis cost-effectiveness of therapy |
|
Multi-drug-resistant tuberculosis cost-effectiveness of therapy in the news |
|
Blogs on Multi-drug-resistant tuberculosis cost-effectiveness of therapy |
|
Directions to Hospitals Treating Multi-drug-resistant tuberculosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Cost-effectiveness of therapy
- The average cost of treating a person with TB disease increases with greater resistance.
- Direct costs (in 2010 U.S. dollars) average from $17,000 to treat drug-susceptible TB to $430,000 to treat the most drug-resistant form of the disease (XDR TB). [1]
- When including productivity losses (e.g., lost income) experienced by patients while undergoing treatment, costs are even higher.[1]
 |